Described are gastrointestinal cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of gastrointestinal cancer.
MORGAN RICHARD [GB]; PANDHA HARDEV S [GB]
Type of Offer:
« More Biotech Patents« More Genetics Patents« More Diagnostic Patents